Evaluation of Aromatherapy on Academic Stress
(EAS)
1 other identifier
interventional
49
1 country
1
Brief Summary
Stress affects the health and is prevalent among medicine and pharmacy students. A number of factors such as busy schedules, course load and lack of recreational time during semesters as well as exams, have been reported to be associated with stress. Study reports that the use of aroma oils especially those with relaxant properties can alleviate the level of stress. This study aims to investigate the effects of aroma oils in stress during exams in pharmacy students.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2018
CompletedFirst Submitted
Initial submission to the registry
February 19, 2018
CompletedFirst Posted
Study publicly available on registry
March 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 5, 2018
CompletedOctober 5, 2021
September 1, 2021
2 months
February 19, 2018
September 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change from baseline perceived academic stress at day 7 and at day 14
For investigating the level of stress during examination, a subjective perceived stress scale would be given to students to report perceived academic stress. The range of this scale is from 0 to 5 where a value of 0 indicate no academic stress and value of 5 indicate severe academic stress.
Day 1 to day 7 till day 14
Change in baseline mean Blood pressure at day 7 and at day 14
For observing any change in mean blood pressure, a blood pressure monitor will be used to determine any variation in blood pressure in millimeters of mercury (mm of Hg). A total of three readings will be taken at baseline day 0, day 7 and day 14. The mean value obtained from three readings will be considered final for each time point.
Day 1 to day 7 till day 14
Change in baseline heart rate at day 7 and at day 14
For observing any change in heart rate, a blood pressure monitor will be used to determine change in heart rate in beats per minute (BPM). A total of three readings will be taken at baseline, day 7 and day 14. The mean value obtained from three readings will be considered final for each time point.
Day 1 to day 7 till day 14
Change in baseline Stool consistency at day 7 and day 14
Bristol stool chart (BST) to indicate the consistency and frequency of stools passed during this period. Bristol stool chart consists of 7 types of stools. It is a subjective assessment.
Day 1 to day 7 till day 14
Change in baseline headache at day 7 and day 14
visual analog scale (VAS) for recording the intensity of headache experienced by students during this period. Visual Analogue Scale consist of a range of 1 to 5. (1 = normal and 5 = extreme). It is a subjective self reporting instrument.
Day 1 to day 7 till day 14
Study Arms (3)
Group-I (Control group)
PLACEBO COMPARATORThis group will be administered a placebo that is an odorless oil without any therapeutic effect)
Group-II (Treated group)
EXPERIMENTALThis group will be administered lavender oil.
Group-III (Untreated group)
NO INTERVENTIONNo intervention will be provided in this group.
Interventions
The oil used in this study will be lavender oil with a final concentration of 3% using almond oil (90%) as diluent. The oil after dilution and final preparation will be converted to proper clean vial in a fix amount (10 ml) and given to the students.
an odorless oil without any therapeutic effect
Eligibility Criteria
You may qualify if:
- The study includes only male student of Pharmacy college at IAU.
- Students from 2nd to 5th year are eligible for the study.
- All the students who are willing to participate voluntarily and are in healthy state will be included in the study.
You may not qualify if:
- Students from other colleges as well as female students are not included in the study.
- Any student who have no consent to participate will be excluded from this study.
- Students with a history of stress, anxiety and depression, with any serious chronic medical conditions, any known allergy to aromatherapy or lavender oil.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of Clinical Pharmacy
Dammam, Eastern Province, 31441, Saudi Arabia
MeSH Terms
Interventions
Study Officials
- STUDY CHAIR
Dr Mastour S Al Ghamdi, PhD
Dean, College of Clinical Pharmacy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Group-I and Group-II will be blinded to the intervention while Group-III would not be administered an intervention.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-Investigator
Study Record Dates
First Submitted
February 19, 2018
First Posted
March 9, 2018
Study Start
February 2, 2018
Primary Completion
April 1, 2018
Study Completion
April 5, 2018
Last Updated
October 5, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- The data will be available after March 5, 2018.
All data pertaining to the clinical trial will be made available after study completion.